Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis

Genes and Development

Volumn 23, Issue 22, 2009, Pages 2563-2577

  Visvader, Jane E ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

BRCA1; Breast cancer; Development; Luminal progenitor; Mammary gland; Stem cell

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA2 INTEGRIN; ALPHA6 INTEGRIN; ATAXIN 1; BETA1 INTEGRIN; BRCA1 PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; CD61 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; MUCIN 1; NOTCH RECEPTOR; STEM CELL FACTOR; THY 1 ANTIGEN; WNT PROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST TUMOR; CELL CYCLE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL ISOLATION; CELL LINEAGE; GENE MUTATION; HUMAN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MUTATION; PREGNANCY; STEM CELLS; UBIQUITIN-PROTEIN LIGASES; WNT PROTEINS;

EID: 72749103664     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1849509     Document Type: Review

References (121)

1. Abrams TJ, Guzman RC, Swanson SM, Thordarson G, Talamantes F, Nandi S. 1998. Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis. Anticancer Res 18: 4115-4121. (Pubitemid 29043622)
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. 2003. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 100: 3983-3988. (Pubitemid 36418143)
3. Artavanis-Tsakonas S, Rand MD, Lake RJ. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284: 770-776. (Pubitemid 29291335)
4. Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ, Visvader JE, Lindeman GJ. 2006. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 98: 1011-1014. (Pubitemid 44288166)
5. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, et al. 2007. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201-209. (Pubitemid 46420863)
6. Asselin-Labat ML, Vaillant F, Shackleton M, Bouras T, Lindeman GJ, Visvader JE. 2008. Delineating the epithelial hierarchy in the mouse mammary gland. Cold Spring Harb Symp Quant Biol 73: 469-478.
7. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. 2009. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
8. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. 2008. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507. (Pubitemid 351601215)
9. Bissell MJ, Labarge MA. 2005. Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment? Cancer Cell 7: 17-23.
10. Booth BW, Smith GH. 2006. Estrogen receptor-α and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands. Breast Cancer Res 8: R49. doi: 10.1186/bcr1538.
11. Booth BW, Mack DL, Androutsellis-Theotokis A, McKay RD, Boulanger CA, Smith GH. 2008. The mammary microenvironment alters the differentiation repertoire of neural stem cells. Proc Natl Acad Sci 105: 14891-14896.
12. Boulanger CA, Wagner KU, Smith GH. 2005. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-β1 expression. Oncogene 24: 552-560.
13. Boulanger CA, Mack DL, Booth BW, Smith GH. 2007. Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc Natl Acad Sci 104: 3871-3876.
14. Bouras T, Pal B, Vaillant F, Harburg G, Asselin-Labat ML, Oakes SR, Lindeman GJ, Visvader JE. 2008. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 3: 429-441.
15. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. 1998. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci 95: 5076-5081. (Pubitemid 28208553)
16. Britt KL, Kendrick H, Regan JL, Molyneux G, Magnay FA, Ashworth A, Smalley MJ. 2009. Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells. Breast Cancer Res 11: R20. doi: 10.1186/bcr2245.
17. Buono KD, Robinson GW, Martin C, Shi S, Stanley P, Tanigaki K, Honjo T, Hennighausen L. 2006. The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy. Dev Biol 293: 565-580.
18. Buszczak M, Spradling AC. 2006. Searching chromatin for stem cell identity. Cell 125: 233-236.
19. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM. 2007. The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13: 2329-2334. (Pubitemid 46698581)
20. Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. 2008. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14: 1368-1376.
21. Chepko G, Smith GH. 1997. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 29: 239-253. (Pubitemid 27197107)
22. Chiba S. 2006. Notch signaling in stem cell systems. Stem Cells 24: 2437-2447. (Pubitemid 44674304)
23. Ciarloni L, Mallepell S, Brisken C. 2007. Amphiregulin is an essential mediator of estrogen receptor a function in mammary gland development. Proc Natl Acad Sci 104: 5455-5460. (Pubitemid 47175701)
24. Clarke RB, Howell A, Potten CS, Anderson E. 1997. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987-4991. (Pubitemid 27498105)
25. Clarke RB, Spence K, Anderson E, Howell A, Okano H, Potten CS. 2005. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277: 443-456. (Pubitemid 40022963)
26. Daniel CW, Young LJ. 1971. Influence of cell division on an aging process. Life span of mouse mammary epithelium during serial propagation in vivo. Exp Cell Res 65: 27-32.
27. Daniel CW, De Ome KB, Young JT, Blair PB, Faulkin LJ Jr. 1968. The in vivo life span of normal and preneoplastic mouse mammary glands: A serial transplantation study. Proc Natl Acad Sci 61: 53-60.
28. De Ome KB, Faulkin LJ Jr, Bern HA, Blair PB. 1959. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19: 515-520.
29. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. 1996. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059.
30. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. 2003. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes & Dev 17: 1253-1270.
31. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. 2004. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6: R605-R615. doi: 10.1186/bcr920.
32. Eirew P, Stingl J, Raouf A, Turashvili G, Aparicio S, Emerman JT, Eaves CJ. 2008. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 14: 1384-1389.
33. Emerman JT, Vogl AW. 1986. Cell size and shape changes in the myoepithelium of the mammary gland during differentiation. Anat Rec 216: 405-415.
34. Fernandez-Gonzalez R, Illa-Bochaca I, Welm BE, Fleisch MC, Werb Z, Ortiz-de-Solarzano C, Barcellos-Hoff MH. 2009. Mapping mammary gland architecture using multi-scale in situ analysis. Integ Biol 1: 80-89.
35. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, et al. 2009. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361: 123-134.
36. Foulkes WD. 2004. BRCA1 functions as a breast stem cell regulator. J Med Genet 41: 1-5.
37. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al. 2007. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
38. Gu B, Sun P, Yuan Y, Moraes RC, Li A, Teng A, Agrawal A, Rheaume C, Bilanchone V, Veltmaat JM, et al. 2009. Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. J Cell Biol 185: 811-826.
39. Gudjonsson T, Villadsen R, Nielsen HL, Ronnov-Jessen L, Bissell MJ, Petersen OW. 2002. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes & Dev 16: 693-706.
40. Gusterson B. 2009. Do 'basal-like' breast cancers really exist? Nat Rev Cancer 9: 128-134.
41. Gusterson BA, Ross DT, Heath VJ, Stein T. 2005. Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res 7: 143-148.
42. Gyorki DE, Asselin-Labat ML, van Rooijen N, Lindeman GJ, Visvader JE. 2009. Resident macrophages influence stem cell activity in the mammary gland. Breast Cancer Res 11: R62. doi: 10.1186/bcr2353.
43. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, et al. 2009. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69: 4116-4124.
44. Hennighausen L, Robinson GW. 2005. Information networks in the mammary gland. Nat Rev Mol Cell Biol 6: 715-725.
45. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, et al. 2007. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8: R76. doi: 10.1186/gb-2007-8-5-r76.
46. Hoshino K, Gardner WU. 1967. Transplantability and life span of mammary gland during serial transplantation in mice. Nature 213: 193-194.
47. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, et al. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351: 657-667.
48. Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, et al. 2008. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study. J Clin Oncol 26: 1331-1337.
49. Kendrick H, Regan JL, Magnay FA, Grigoriadis A, Mitsopoulos C, Zvelebil M, Smalley MJ. 2008. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 9: 591. doi: 10.1186/1471-2164-9-591.
50. Kordon EC, Smith GH. 1998. An entire functional mammary gland may comprise the progeny from a single cell. Development 125: 1921-1930.
51. Korkaya H, Paulson A, Charafe-Jauffret E, Ginestier C, Brown M, Dutcher J, Clouthier SG, Wicha MS. 2009. Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling. PLoS Biol 7: e1000121. doi: 10.1371/journal.pbio.1000121.
52. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z. 2008. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13: 141-152.
53. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA. 2004. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci 101: 4966-4971. (Pubitemid 38469186)
54. Kustikova O, Fehse B, Modlich U, Yang M, Dullmann J, Kamino K, von Neuhoff N, Schlegelberger B, Li Z, Baum C. 2005. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308: 1171-1174. (Pubitemid 40696434)
55. Lakhani SR, Slack DN, Hamoudi RA, Collins N, Stratton MR, Sloane JP. 1996. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 74: 129-135. (Pubitemid 26041015)
56. Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J, Rivas C, Bignon YJ, et al. 2005. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11: 5175-5180.
57. Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. 1994. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331: 5-9. (Pubitemid 24195593)
58. Land CE, McGregor DH. 1979. Breast cancer incidence among atomic bomb survivors: Implications for radiobiologic risk at low doses. J Natl Cancer Inst 62: 17-21.
59. Lee CW, Simin K, Liu Q, Plescia J, Guha M, Khan A, Hsieh CC, Altieri DC. 2008. A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res 10: R97. doi: 10.1186/bcr2200.
60. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, et al. 2003. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci 100: 15853-15858. (Pubitemid 38021079)
61. Li N, Li H, Cherukuri P, Farzan S, Harmes DC, DiRenzo J. 2006. TA-p63-g regulates expression of DN-p63 in a manner that is sensitive to p53. Oncogene 25: 2349-2359.
62. Li W, Ferguson BJ, Khaled WT, Tevendale M, Stingl J, Poli V, Rich T, Salomoni P, Watson CJ. 2009. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci 106: 4725-4730.
63. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat M-L, Gyorki DE, Ward T, Partanen A, et al. 2009. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-913.
64. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW. 2003. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163: 2113-2126. (Pubitemid 37310040)
65. Liu BY, McDermott SP, Khwaja SS, Alexander CM. 2004. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci 101: 4158-4163.
66. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS. 2006. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071.
67. Liu X, Holstege H, van der Gulden H, Treur-Mulder M, Zevenhoven J, Velds A, Kerkhoven RM, van Vliet MH, Wessels LF, Peterse JL, et al. 2007. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci 104: 12111-12116. (Pubitemid 47185638)
68. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wicha MS. 2008. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci 105: 1680-1685. (Pubitemid 351346574)
69. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S. 1970. Age at first birth and breast cancer risk. Bull World Health Organ 43: 209-221.
70. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, et al. 2009. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 11: 162-171.
71. Mallepell S, Krust A, Chambon P, Brisken C. 2006. Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci 103: 2196-2201. (Pubitemid 43271646)
72. Molofsky AV, Pardal R, Morrison SJ. 2004. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 16: 700-707. (Pubitemid 39467731)
73. Moraes RC, Zhang X, Harrington N, Fung JY, Wu MF, Hilsenbeck SG, Allred DC, Lewis MT. 2007. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development 134: 1231-1242. (Pubitemid 46630090)
74. Narod SA. 2006. Modifiers of risk of hereditary breast cancer. Oncogene 25: 5832-5836. (Pubitemid 44453438)
75. Narod SA, Foulkes WD. 2004. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4: 665-676.
76. Neville MC, Medina D, Monks J, Hovey RC. 1998. The mammary fat pad. J Mammary Gland Biol Neoplasia 3: 109-116.
77. Oakes SR, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton HN, Kazlauskas M, Pritchard MA, Chodosh LA, Pfeffer PL, et al. 2008. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes & Dev 22: 581-586. (Pubitemid 351342431)
78. Palacios J, Honrado E, Osorio A, Cazorla A, Sarrio D, Barroso A, Rodriguez S, Cigudosa JC, Diez O, Alonso C, et al. 2005. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res Treat 90: 5-14.
79. Parmar H, Young P, Emerman JT, Neve RM, Dairkee S, Cunha GR. 2002. A novel method for growing human breast epithelium in vivo using mouse and human mammary fibroblasts. Endocrinology 143: 4886-4896. (Pubitemid 35397628)
80. Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY, Ho IC, Perou CM, Xiong Y. 2009. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell 15: 389-401.
81. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. 2000. Molecular portraits of human breast tumours. Nature 406: 747-752.
82. Pierce DF Jr, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, Daniel CW, Hogan BL, Moses HL. 1993. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β 1. Genes & Dev 7: 2308-2317.
83. Pietersen AM, Evers B, Prasad AA, Tanger E, Cornelissen-Steijger P, Jonkers J, van Lohuizen M. 2008. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr Biol 18: 1094-1099.
84. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. 2008. Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
85. Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, Iscove N, Jones S, McKinney S, Emerman J, et al. 2008. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 3: 109-118.
86. Reya T, Clevers H. 2005. Wnt signalling in stem cells and cancer. Nature 434: 843-850. (Pubitemid 40558990)
87. Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH. 2005. Breast differentiation and its implication in cancer prevention. Clin Cancer Res 11: 931s-936s.
88. Schedin P. 2006. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6: 281-291.
89. Scully KM, Gleiberman AS, Lindzey J, Lubahn DB, Korach KS, Rosenfeld MG. 1997. Role of estrogen receptor-α in the anterior pituitary gland. Mol Endocrinol 11: 674-681.
90. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. 2006. Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88.
91. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, et al. 2007. Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-273.
92. Silberstein GB. 2001. Postnatal mammary gland morphogenesis. Microsc Res Tech 52: 155-162.
93. Silberstein GB, Flanders KC, Roberts AB, Daniel CW. 1992. Regulation of mammary morphogenesis: Evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-β 1. Dev Biol 152: 354-362.
94. Siwko SK, Dong J, Lewis MT, Liu H, Hilsenbeck SG, Li Y. 2008. Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells - Implications for pregnancy-induced protection against breast cancer. Stem Cells 26: 3205-3209.
95. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182.
96. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. 2006. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 8: R7. doi: 10.1186/bcr1371.
97. Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, Smalley MJ. 2007. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 176: 19-26.
98. Smith GH. 1996. Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat 39: 21-31.
99. Smith GH. 2005. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 132: 681-687.
100. Smith GH, Medina D. 1988. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J Cell Sci 90: 173-183. (Pubitemid 18128164)
101. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci 98: 10869-10874. (Pubitemid 32878711)
102. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET. 2003. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci 100: 10393-10398. (Pubitemid 37071889)
103. Sparmann A, van Lohuizen M. 2006. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6: 846-856. (Pubitemid 44629896)
104. Stingl J, Eaves CJ, Zandieh I, Emerman JT. 2001. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 67: 93-109. (Pubitemid 32744490)
105. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. 2006. Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997. (Pubitemid 43292419)
106. Stylianou S, Clarke RB, Brennan K. 2006. Aberrant activation of notch signaling in human breast cancer. Cancer Res 66: 1517-1525. (Pubitemid 43259933)
107. Taddei I, Deugnier MA, Faraldo MM, Petit V, Bouvard D, Medina D, Fassler R, Thiery JP, Glukhova MA. 2008. β1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 10: 716-722.
108. Tanentzapf G, Devenport D, Godt D, Brown NH. 2007. Integrin-dependent anchoring of a stem-cell niche. Nat Cell Biol 9: 1413-1418.
109. Teuliere J, Faraldo MM, Deugnier MA, Shtutman M, Ben-Ze'ev A, Thiery JP, Glukhova MA. 2005. Targeted activation of β-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 132: 267-277.
110. Tsai YC, Lu Y, Nichols PW, Zlotnikov G, Jones PA, Smith HS. 1996. Contiguous patches of normal human mammary epithelium derived from a single stem cell: Implications for breast carcinogenesis. Cancer Res 56: 402-404. (Pubitemid 26026371)
111. Turner N, Tutt A, Ashworth A. 2004. Hallmarks of 'BRC Aness' in sporadic cancers. Nat Rev Cancer 4: 814-819.
112. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. 2008. The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 68: 7711-7717.
113. Venkitaraman AR. 2002. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182.
114. Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L, Gudjonsson T, Rank F, LaBarge MA, Bissell MJ, Petersen OW. 2007. Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol 177: 87-101. (Pubitemid 46588404)
115. Voduc D, Cheang M, Nielsen T. 2008. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomarkers Prev 17: 365-373. (Pubitemid 351272788)
116. Wagner KU, Smith GH. 2005. Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia 10: 25-36.
117. Welm BE, Dijkgraaf GJP, Bledau AS, Welm AL, Werb Z. 2008. Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. Cell Stem Cell 2: 90-102.
118. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM. 2007. WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci 104: 618-623. (Pubitemid 46123074)
119. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX. 1999. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22: 37-43. (Pubitemid 29214802)
120. Yamaji D, Na R, Feuermann Y, Pechhold S, Chen W, Robinson GW, Henninghausen L. 2009. Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes & Dev 20: 2382-2387.
121. Zhou J, Chehab R, Tkalcevic J, Naylor MJ, Harris J, Wilson TJ, Tsao S, Tellis I, Zavarsek S, Xu D, et al. 2005. Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. EMBO J 24: 635-644. (Pubitemid 40343264)